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Abstract: The European Heart Journal – Cardiovascular Imaging was launched in 2012. It has
gained an impressive impact factor of 8.336 during its first 6 years and is now
established as one of the top 10 cardiovascular journals in the world and the most
important cardiovascular imaging journal in Europe.
The most important studies published in the journal in 2017 will be highlighted in 2
reports. Part I will focus on studies about myocardial function, coronary artery disease
and myocardial ischaemia, emerging techniques and applications in cardiovascular
imaging, while Part II will focus on valvular heart disease, heart failure,
cardiomyopathies, and congenital heart disease.
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The European Heart Journal – Cardiovascular Imaging has successfully evolved as a 
multimodality imaging journal during its first 6 years. The journal has now an important role 
as a significant resource for cardiologists, specialists in all imaging modalities, and other 
physicians working in the field of cardiovascular imaging. The tradition of highlighting the 
most important studies that were published in the previous year is continued.1,2 The most 
important papers published in the journal in 2017 will be summarized in two articles. Part I is 
focused on studies about normal reference ranges and myocardial function, coronary disease 
and myocardial ischaemia, and emerging techniques and applications in cardiovascular 
imaging. 
Normal reference ranges and myocardial function 
Normal ranges for 2D echocardiographic measurements of left ventricular (LV) strain 
from 549 healthy volunteers were published from the European Association of 
Cardiovascular Imaging (EACVI) NORRE study. The lowest expected values of LV strains 
(calculated as ± 1.96 standard deviations from the mean) were -16.7% in men and -17.8% in 
women for longitudinal strain, -22.3% and -23.6% for circumferential strain, and 20.6% and 
21.5% for radial strain, respectively. Longitudinal strain decreased with age whereas the 
opposite occurred with circumferential and radial strain. Male gender was associated with 
lower strain for longitudinal, circumferential, and radial strain. Inter-vendor differences were 
observed for circumferential and radial strain despite the use of vendor-independent software. 
Importantly, no inter-vendor differences were noted in longitudinal strain.3 
Analysing data from 440 healthy subjects enrolled in the same NORRE study, the 3D 
echocardiographic reference ranges for normal LV volumes, function and strain were 
reported. Upper limits of LV end-diastolic and end-systolic volumes were larger in men (97 
and 42 mL/m2) than in women (82 and 35 mL/m2; P < 0.0001) and lower limits of LV 
ejection fraction were higher in women than in men (51% vs. 50%; P < 0.01).4 
Manuscript
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Morris and coworkers analysed a large cohort of 238 healthy subjects and 642 patients 
with heart failure with the purpose of determining the normal range and the usefulness of 
right ventricular (RV) systolic strain to detect subtle RV systolic abnormalities using 2D 
speckle-tracking echocardiography. The normal range of RV systolic strain in the healthy 
subjects was as follows: RV global strain −24.5 ± 3.8% and RV free wall strain −28.5 ± 4.8% 
(lowest expected values −17 and −19%, respectively).5 
Another report from the NORRE study provides normal values of proximal aorta 
dimensions as assessed by echocardiography. Saura et al reported reference ranges for 
different anatomical levels using different measurement conventions at different times of the 
cardiac cycle. Age, gender, and body size were significant determinants of aortic 
dimensions.6 
Schaaf et al aimed to evaluate whether 2D and 3D echocardiographic (2DE and 3DE) 
assessment of left atrial anatomy and function was able to identify patients with paroxysmal 
atrial fibrillation. Anatomical and functional left atrial remodelling assessed by 2DE and 3DE 
was independently and strongly associated with paroxysmal atrial fibrillation, suggesting that 
these parameters can help identify this arrhythmia.7 
Ternacle et al assessed the time course and mechanisms of metabolic and cardiac 
modifications induced by short-term high-fat diet in wild-type mice. The high-fat diet 
promoted early metabolic and cardiac dysfunctions, and adipose and myocardial tissues 
remodelling.8 
Maufrais et al analysed the underlying mechanisms of LV and RV functional 
alterations during several days in high-altitude hypoxia. High-altitude exposure impaired LV 
diastolic function with the greatest effect observed at day 2, concomitantly with the 
occurrence of acute mountain sickness. The LV early filling impairments resulted from an 
increased RV afterload, a decrease in LV filling pressure and a delayed LV untwist.9 
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Two cardiovascular magnetic resonance (CMR) studies provide new insights into 
different forms of pathological LV hypertrophy. Arenja and colleagues assessed the 
diagnostic value of myocardial contraction fraction to distinguish left ventricular hypertrophy 
(LVH) from controls and then specifically to distinguish different aetiologies of LV 
hypertrophy. The functional measure of myocardial contraction fraction had an excellent area 
under the curve of 0.96 to detect LVH ranging from 0.92 for hypertensive heart disease, 0.94 
for transthyretin amyloidosis, 0.97 for hypertrophic cardiomyopathy and 0.99 for light chain 
amyloidosis. Interestingly, cut-off values of myocardial contraction fraction <50% allowed 
the identification of patients with cardiac amyloidosis.10 Kozor and colleagues included also 
LVH caused by hypertension, cardiac amyloidosis and hypertrophic cardiomyopathy, but 
additionally also patients with Fabry disease and aortic stenosis. They found disproportionate 
hypertrophy of LV papillary muscle in hypertrophic cardiomyopathy and patients without 
and with LVH linked to Fabry disease.11  
A substudy of the Multi-Ethnic Study of Atherosclerosis (MESA) included 536 participants 
with diabetes mellitus with 11.4 years of follow-up for incident cardiovascular disease. In a 
multivariate analysis, CMR determined left atrial minimum volume and left atrial function 
were found to be of prognostic value in these participants free of cardiovascular disease at 
baseline.12 
Coronary artery disease and myocardial ischemia 
Cardiac computed tomography and CMR led the field of research in the area of 
imaging in coronary artery disease in 2017. Still, many valuable documents have been 
published on the role of ultrasound imaging as a first tool for diagnosing and assessing 
myocardial ischemia.  
In an interesting study, consecutive patients with suspected stable angina, without 
known coronary artery disease (CAD) were randomized to exercise ECG stress test (194 
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patients), or exercise echocardiography (191 patients). Exercise echocardiography was more 
effective and demonstrated superior cost-saving compared with exercise ECG when used as 
the initial investigation for the evaluation of CAD in patients with new-onset suspected stable 
angina without known CAD.13 
In another study, dobutamine stress echocardiography was performed in 250 patients 
with angina who were afterwards diagnosed with significant coronary artery disease (≥50% 
stenosis in the left main and/or ≥70% in other arteries) at coronary angiography. The study 
showed that in all phases of dobutamine stress echocardiography global and regional LV 
peak systolic longitudinal strain were lower in patients with diabetes, independently of the 
presence of significant coronary artery disease. The diabetic cardiomyopathy is altering the 
strain values independently of any significant epicardial coronary artery disease.14 
Cortigiani et al sought to investigate the capability of power/mass assessed at peak of 
dobutamine stress echocardiography to predict mortality in patients with ischaemic 
cardiomyopathy and no inducible ischaemia. Power/mass assessed allowed effective 
prognostication in these patients who were test result negative by wall motion criteria. In 
particular, a peak-stress power/mass ≤50 W/100 g was a strong and multivariable predictor of 
mortality.15 
A large multi-center study has been conducted in Israel on 605 patients, of which 74 
(12.2%) had acute coronary syndromes (ACS). The aim was to determine whether 2D-
longitudinal strain analysis could assist in the triage of patients with chest pain in the 
emergency department. Acute coronary syndrome was not among the independent predictors 
of abnormal 2D longitudinal strain. The area under the curve for global longitudinal strain 
(GLS) to predict the ACS was only 0.6. Thus, in this study GLS was not a useful tool to rule 
out ACS in the emergency department.16 
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An important recommendation document was published by the EACVI about the 
modern use of contrast echocardiography.17 The use of contrast in echocardiography has 
extended beyond the assessment of cardiac structure and function to the evaluation of 
myocardial perfusion. The document, based on clinical trials, randomized and multicentre 
studies and published clinical experience, established clear recommendations for the use of 
contrast in various clinical conditions with evidence-based protocols.17 
Coronary CT angiography (CTA) is an excellent imaging modality to characterize and 
quantify coronary atherosclerotic plaques. Adverse plaque characteristics (low plaque 
attenuation, positive remodelling, napkin-ring sign and spotty calcium) and global coronary 
plaque burden as assessed by coronary CTA have been associated with future cardiac events. 
Several studies published in the journal last year consistently demonstrated the long-term 
prognostic value of adverse plaque characteristics and global plaque burden.  
A study on 1469 patients with an overall follow-up time of 7.8 years showed that the 
prognosis is excellent over a long-term period if coronary CTA is negative and that low-
attenuation plaque defined as any voxel with 60 HU and the presence of napkin-ring sign 
are the most powerful predictors of cardiovascular events even after adjusting for 
conventional risk factors and CT stenosis severity.18 In line with these findings a smaller 
study, with a follow-up time of 8.2 years, concluded that positive remodelling, napkin-ring 
sign, low attenuation plaque and increased plaque burden are associated with increased risk 
among patients with non-obstructive CAD.19 Similarly, a case control study showed that total 
non-calcified and low-attenuation plaque volumes predict cardiac death during a mean 
follow-up time of 5 years.20 The CONFIRM (COronary CT Angiography EvaluatioN For 
Clinical Outcomes: An InteRnational Multicenter) study is one of the largest prospective 
coronary CTA registry collecting clinical, procedural, and follow-up data of patients 
undergoing coronary CTA for clinically indicated reasons. The authors demonstrated that the 
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CONFIRM score combining established clinical risk parameters and the presence of non-
obstructive proximal partially calcified or calcified plaques as well as proximal lumen 
narrowing of ≥50% permits a significantly improved prediction of mortality over clinical risk 
scores for 5 years after coronary CTA.21 Importantly, these findings were consistent in a 
large variety of patient subgroups and were independent of aspirin and statin treatment at 
baseline. In addition, the CONFIRM investigators demonstrated that early revascularization 
after coronary CTA is associated with a reduced mortality at 5 years in patients with high-risk 
CAD. However, they did not find a benefit from early revascularization in patients with low-
risk CAD.22 
The prevalence of obstructive CAD in symptomatic patients with zero-coronary 
calcium score and the associated long-term risk remain controversial. The clinical outcomes 
of this challenging patient population were investigated in a study on 3914 patients with a 
follow-up time of 5.2 years. The study demonstrated that zero calcium score has a negative 
predictive value of 99.5% for excluding >70% stenosis on coronary CTA and the annual 
event rate was 0.3% for those with zero compared with 1.2% for non-zero calcium scores. 
Based on these observations it seems that the presence of non-calcified plaque on coronary 
CTA in patients with zero calcium score does not affect prognosis, therefore zero calcium 
score may be a safe ‘gatekeeper’ in this patient cohort obviating the need for additional 
expensive tests.23 
The last year brought several interesting and innovative projects in the field of 
functional assessment of CAD with cardiac CT. The evidence supporting CT based FFR 
simulation (FFRCT) and myocardial perfusion imaging (MPI) is accumulating.24 It has been 
demonstrated by several large multicentre trials that FFRCT has high diagnostic performance 
in stable CAD. A recent study has analysed the diagnostic performance of FFRCT, in patients 
with hypertension and diabetes, who are at risk of microvascular impairment. The 
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investigators found that FFRCT is a robust method in a broad stable CAD population, 
including patients at high risk for microvascular disease.25 Another study has investigated the 
utility of FFRCT in the follow-up of patients with second iteration bioresorbable vascular 
scaffold (BVS). Cardiac CT was performed at 18 months and 72 months in 53 patients with 
BVS. Interestingly, in 39 patients with serial coronary CTA analyses, the minimal luminal 
area increased significantly from the first to the second follow-up coronary CTA (delta = 
0.80mm2, P=0.002) (Figure 1). The study showed that long-term serial coronary CTA with 
FFRCT assessment of bioresorbable scaffold is feasible and the results demonstrated late 
lumen enlargement with the persistence of normalization of the FFRCT.26 Stress CT 
perfusion in patients with obstructive CAD at coronary CTA in the same setting reduced the 
referral rate for invasive coronary angiography and revascularization.27 Importantly, the 
authors demonstrated that the occurrence of major cardiovascular events at 12 months 
follow-up in patients with normal stress CTP is low, thus deferral of invasive coronary 
angiography based on negative stress CTP seems to be a safe diagnostic strategy with an 
extra effective radiation dose of 3.1 (2.3–4.4) mSv (k=0.014 mSv/mGy/cm). The same group 
has investigated the influence of heart rate, medication use, and patient characteristics on 
image interpretability of stress myocardial CTP examinations and concluded that increasing 
heart rate during the acquisition of adenosine stress myocardial CTP is related to worse 
image interpretability. 28  
Another challenging clinical scenario is represented by patients with stable chest pain 
and absence of obstructive CAD, which raises the suspicion of coronary microvascular 
dysfunction (CMD). In a prospective study, 189 patients with intermediate pre-test 
probability of CAD underwent hybrid imaging with coronary CTA and quantitative 15O-
water PET perfusion imaging followed by invasive coronary angiography, and assessment of 
fractional flow reserve. The study demonstrated that CMD identified as abnormal vasodilator 
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capacity by PET perfusion imaging exists in 9% of patients with stable chest pain and 
suspected CAD. Importantly, CMD without any coronary atherosclerosis was rare (1%) in 
this population (Figure 2).29 On the other hand, chronic coronary total occlusions (CTO) are 
quite common and are encountered in up to one-third of patients with known or suspected 
CAD. A 15O-water PET study of 76 consecutive patients with CTO has demonstrated that 
even in the presence of angiographically well-developed collateral arteries, the vast majority 
of CTO patients with preserved LVEF display significantly impaired perfusion. These results 
suggest that collateral function during increased blood flow demand in viable myocardium is 
predominantly insufficient and that revascularization should be considered.30 The importance 
of respiratory phase matching between single-photon-emission computed tomography 
myocardial perfusion imaging (SPECT-MPI) and low-dose computed tomography (CT) for 
attenuation correction (AC) was assessed in a prospective study. Forty patients underwent 1-
day 99mTc-tetrofosmin pharmacological stress/rest SPECT-MPI using a cadmium–zinc–
telluride gamma camera. Low-dose CT for AC was performed at deep-inspiration breath-
hold. SPECT-MPI was acquired once with free-breathing (FB) and repeated at deep-
inspiration breath-hold (BH) to match the respiratory phase of AC. Compared with non-
corrected breath-hold SPECT-MPI and with free-breathing AC SPECT-MPI, respiratory-
phase- matched AC SPECT-MPI significantly affected segmental semi-quantitative uptake, 
increased the frequency of normal scans, yielded the best interobserver agreement and 
significantly improved image quality. These findings suggest a potential role of respiratory 
triggered SPECT-MPI in clinical routine. 31 
Splenic perfusion is reduced during adenosine and on CMR stress perfusion this can be 
observed as the ‘splenic switch off’ phenomenon. Hosking and colleagues validated splenic 
switch-off in a cohort derived from over 23,000 patients with CMR perfusion scans in whom 
follow-up data was available including invasive coronary angiograms within 12 months if 
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performed. The rate of lack of splenic switch-off was 20.7% in patients with false negative 
adenosine CMR stress perfusion scans and only 13.1% in patients with true positive 
adenosine CMR stress perfusion scans. Splenic switch-off can easily be visually assessed, but 
also quantification is simple and fast. A cut-off of 0.4 for spleen intensity ratio (comparison 
between adenosine stress and rest signal intensity in the spleen) has 82.5% sensitivity and 
92.3% specificity to identify splenic switch-off. Thus, splenic switch-off is a promising and 
now commonly used method to determine whether adenosine response is adequate.32  
A few studies published in this journal in 2017 reported the high diagnostic accuracy of CMR 
in significant CAD. Adenosine CMR first pass myocardial perfusion imaging allows 
assessment of global and regional alterations in myocardial blood flow. Theoretically, 
balanced ischaemia in three vessel disease may be visually missed on CMR first pass 
perfusion imaging. Global myocardial blood flow reserve can also be determined by 
assessing the flow in the coronary sinus during adenosine and at rest. Shomanova and 
colleagues performed a study using these two approaches in patients with and without 
obstructive coronary artery disease and found that the combination provided higher 
diagnostic yield compared to myocardial first pass perfusion reserve alone. However, on its 
own the coronary sinus blood flow based approach cannot determine the location of 
obstructive coronary disease.33 
In a multi-centre study of 106 female and 251 male patients who underwent 3D CMR first-
pass perfusion imaging which was compared to invasive fractional flow reserve assessment 
as the reference standard, Harmada and colleagues showed that diagnostic accuracy was at 
least as good in women (sensitivity/specificity 95%/84%) as in men (sensitivity/specificity 
83%/82%). Thus, whole-heart first-pass 3D CMR stress perfusion imaging has high 
diagnostic accuracy irrespective of gender.34 
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CMR stress perfusion has been shown in the past to have excellent prognostic value with 
negative studies having a very low annualised event rate. This has now been confirmed in a 
meta-analysis comparing the prognostic value of negative non-invasive cardiac investigations 
in patients with suspected or known coronary artery disease.35 Coronary CT angiography, 
CMR, exercise and pharmacological stress echocardiography and single-photon emission 
tomography all have very low annualised event rates, in particular after adjusting for 
population event risk and prevalence of obstructive CAD. 
The Tayside Screening for Cardiac Events study enrolled 5000 volunteers aged >40 years 
with no prior history of coronary artery disease and a low to intermediate 10-year risk of 
cardiovascular events and performed CMR scans including late gadolinium enhancement. In 
this middle aged population - unlike in previously described studies of older people including 
patients with coronary artery disease - they observed that the prevalence of silent myocardial 
infarction was very low (0.2%).36 
Contrast-enhanced CMR was used to assess area at risk, infarct size and microvascular 
obstruction in patients following reperfused ST-elevation myocardial infarction. 41% of the 
727 patients were smokers. Reinstadler and colleagues demonstrated that there is little 
evidence to support the ‘smoker’s paradox’, which claimed that smokers have better 
myocardial tissue perfusion and outcomes after myocardial infarction. The CMR area at risk, 
infarct size and microvascular obstruction and major adverse cardiac events (after adjustment 
for baseline differences) were similar between smokers and nonsmokers.37 
Emerging techniques and applications in cardiovascular imaging 
Using 2D speckle tracking echocardiography (STE) Huttin et al38 tried to demonstrate 
the relations between mitral valve prolapse (MVP) and LV deformation. There was no 
significant difference between control subjects and patients with MVP with respect to global 
and regional peak LV longitudinal strain (−23.7 ± 3.2% vs. −23.1 ± 2.2%). In contrast, 
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patients with MVP had significantly higher values of global pre-stretch index (3.2 ± 4.1 vs. 
1.3 ± 1.2; P = 0.01) and global post-systolic index (3.2 ± 0.4 vs. 1.7 ± 1.1; P = 0.05) 
compared with controls, located mainly in the lateral wall and basal segments. Both anterior 
and posterior MVP were responsible for post-systolic index in basal inferior segments and 
pre-stretch index in anterior ones. Changes in mid-wall segmental deformation pattern were 
mainly observed at the level of the segments adjacent to the papillary muscle. Pathological 
early-systolic shortening and late/post-systolic deformation is attributed to an increased 
interaction between wall deformation and mitral valve events in patients with MVP.38 
Analysing 41 consecutive genotyped family members of hypertrophic 
cardiomyopathy patients without LVH, Kauer et al39 found no significant differences 
between genotype +, LVH – (G+/LVH−) and control subjects in maximal systolic twist and 
global longitudinal strain. In diastole, the early peak untwist rate was significantly lower in 
G+/LVH− subjects compared with control subjects (62 ± 19°s − 1 vs. 76 ± 30°s − 1, P <0.05), 
whereas the late peak untwist rate tended to be higher. Untwist from maximal twist until the 
first 20% of diastole was delayed in G+/LVH− subjects compared with controls 
(39.3 ± 12.9% vs. 51.3 ± 15.6%, P <0.005). Late diastolic strain rate was significantly higher 
in G+/LVH− subjects in the inferoseptal, the inferolateral, and the anteroseptal walls. Strain 
from maximal twist until the first 20% of diastole was delayed in G+/LVH− subjects in the 
inferoseptal, inferolateral, and anteroseptal segments. In mutation carriers for HCM, LV 
untwist and early diastolic strain are delayed, while untwist rate and diastolic strain rate are 
decreased.39 
A new software tool for automated segmentation and quantification of the left atrium 
(LA) from 3D echocardiography was validated by Almeida et al.40 The LA segmentation tool 
uses a dual-chamber model of the left side of the heart to automatically detect and track the 
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atrio-ventricular plane and the LA endocardium in transthoracic 3D echocardiography. The 
automated tool required no user interaction in 93% of the recordings.40 
Coronary imaging with two or three imaging modalities is time consuming and is 
associated with risk of complications. However, it provides incremental information about 
plaque pathology and biology allowing complete and comprehensive assessment of plaque 
morphology. Michail et al41 review the current clinical evidence supporting the use of 
multimodality intravascular imaging in the study of atherosclerosis, summarize the key 
findings of the first invasive imaging studies that utilize hybrid dual-probe catheters, and 
discuss the limitations of combined intravascular imaging that restrict its wider application in 
both the clinical and the research arena.41 
The diagnosis of intraplaque haemorrhage, a major contributor to lesion progression, 
is very challenging. Matsumura et al42 have analysed the role of intravascular ultrasound 
(IVUS) and near-infrared spectroscopy (NIRS), comparing the results obtained with these 
two emerging techniques with histopathology. Segments with intraplaque haemorrhage had 
more fibroatheromas (FAs) with a greater IVUS plaque burden, a greater prevalence of IVUS 
echolucent zones, and a higher NIRS-lipid core burden index (LCBI) compared to segments 
without intraplaque haemorrhage.42 
The fusion imaging of coronary anatomy by coronary CTA with 3D echocardiography 
(3DE)-derived resting myocardial deformation was tested by Maffesanti et al43 in 28 patients 
with chest pain, referred for coronary CTA (256 Philips scanner) who underwent 3DE and 
regadenoson stress. To obtain a reference for stenosis significance, coronary arteries were 
also fused with colour maps of stress myocardial perfusion. 3D displays were used to detect 
stress perfusion defect and/or resting strain abnormality in each territory. Fusion of coronary 
CTA and 3DE-derived data allows direct visualization of each coronary artery and strain in 
its territory. In this feasibility study, resting strain showed good agreement with stress 
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perfusion (79% agreement), indicating that it may be potentially used to assess the 
haemodynamic impact of coronary stenosis, as an alternative to stress testing that entails 
additional radiation exposure.43 
CMR late gadolinium enhancement is one of the CMR bread and butter techniques 
which allows detection of regional myocardial fibrosis or scar in the left myocardium. Atrial 
late gadolinium enhancement is far more challenging given the thinness of the atrial wall. To 
date, no attempt had been made in humans in vivo to image fibrotic structures within the 
atrial wall, such as the sinoatrial node. Csepe and colleagues used 3D contrast-enhanced 
CMR at 3 Tesla in healthy volunteers with a spatial resolution of 0.625 x 0.625 x 1.25 mm3 
and were able to depict an ellipsoid fibrotic region of 23.6 x 7.2 x 2.9 mm3 corresponding to 
the location of the sinoatrial node. This method was then validated in the same manuscript in 
explanted donor hearts ex vivo at 9.4 Tesla and the same findings of an ellipsoid fibrotic 
region correlated with histological specimens of the sinoatrial node.44 
Structural heart disease imaging and intervention planning became a mainstream 
application of cardiac CT imaging. Calcification is the dominant mechanism of progressive 
aortic valve obstruction in the majority of elderly patients with severe aortic stenosis (AS). 
Nonetheless, in some cases patients with low aortic valve calcification are diagnosed with 
haemodynamically severe AS. In a retrospective study of 563 patients with severe 
symptomatic AS that underwent balloon-expandable transcatheter aortic valve implantation 
(TAVI) the authors assessed the clinical and haemodynamic characteristics and outcome of 
patients with severe AS and low valve calcification. Patients with severe AS and low aortic 
valve calcification were found to be younger and to have a higher BMI. Importantly, balloon-
expandable TAVI in patients with mildly calcified aortic valve was not associated with 
increased risk of valve embolization. In addition, the authors demonstrated a high device 
success and lower rates of paravalvular regurgitation for these patients.45 Another important 
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aspect of pre-procedural TAVI planning with cardiac CT is the possibility to determine the 
optimal fluoroscopic projection for prosthesis implantation, which reduces the volume of 
periprocedural contrast agent compared with an angiography-based approach without an 
increase of complications.46 Beyond TAVI planning, cardiac CT became indispensable in 
sizing work-up for percutaneous left atrial appendage closure. A single-centre registry 
demonstrated that the routine incorporation of CT is associated with excellent outcomes for 
procedural safety and no major residual leak was observed. The authors suggested that a 
particular value of CT in left atrial appendage closure may be the detection and subsequent 
avoidance of gross sizing error by 2D TOE that occurs in a small but important proportion of 
cases.47 Among original articles regarding the assessment of the myocardium using CT an ex 
vivo small animal study on X-ray phase-contrast CT showed us the latest directions of CT 
development. Phase contrast images are formed not only by X-ray absorption by the tissue 
but also by wave propagation phenomena, enhancing structural information, thus allowing to 
raise tissue contrast to an unprecedented level. In this ex vivo study small animal hearts’ 
micro-structure at myofibre resolution was imaged (Figure 3). This superior imaging 
approach opens up new possibilities for a systems approach towards analysing cardiac 
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Figure 1. Case example of serial coronary CTA with FFRCT improvement at follow-up. Case example 
of a patient treated with a Bioresorbable Vascular Scaffold (white arrows) in the proximal segment of 
the LAD. Coronary CTA at 18 months showed a moderate in-scaffold stenosis with MLA 3.4 mm2 
(dash line C) with area stenosis of 64%. At 72-month Coronary CTA follow-up, showed an increased 
MLA to 7.0 mm2 (dash line C) and area stenosis of 30%. This late lumen enlargement had a significant 
impact on FFRCT distal to the scaffold. FFRCT, Non-invasive fractional flow reserve derived from 
coronary computed tomography angiography; LAD, Left anterior descending artery; MLA, Minimal 
lumen area. (Modified from Onuma et al.26). 
Figure 2. Coronary microvascular dysfunction in the absence of atherosclerosis in a 58-year-old man 
with atypical angina pectoris, history of smoking, family history of coronary artery disease, and 
ischaemia on exercise ECG. Myocardial blood flow (MBF) during adenosine stress was moderately 
reduced in all vessel areas (A, global MBF 1.9 mL/g/min). MBF at rest was homogenously distributed 
(B) and CFR was reduced being 2.2. Coronary CT angiography images show the absence of 
atherosclerosis in the left anterior descending (C) and circumflex (D) arteries and the right coronary 
artery (E). Invasive coronary angiogram shows non-obstructed left (F) and right (G) coronary arteries. 
(Modified from Stenstrom et al.29).  
Figure 3. Fibre orientation X-ray phase contrast CTT imaging. Fibre angles change across the walls 
within a slice in fetal rabbit control (A) and in intrauterine growth restriction (B) hearts. Fibre angles 
change from endo- to epi-cardium from +60 to -60. In the C and D, a visualization of the 3D fibre 
structure of the IUGR rabbit heart is shown (left: fibre angles within one slice; right: 3D fibre tracking 
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